Three Amino Acid Substitutions in the L Protein of the Human Parainfluenza Virus Type 3 cp45 Live Attenuated Vaccine Candidate Contribute to Its Temperature-Sensitive and Attenuation Phenotypes
Skiadopoulos, M H, Durbin, A P, Tatem, J M, Wu, S L, Paschalis, M, Tao, T, Collins, P L, Murphy, B R
Published in Journal of Virology (01.03.1998)
Published in Journal of Virology (01.03.1998)
Get full text
Journal Article
Recovery of a Fully Viable Chimeric Human Parainfluenza Virus (PIV) Type 3 in Which the Hemagglutinin-Neuraminidase and Fusion Glycoproteins Have Been Replaced by Those of PIV Type 1
Tao, T, Durbin, A P, Whitehead, S S, Davoodi, F, Collins, P L, Murphy, B R
Published in Journal of Virology (01.04.1998)
Published in Journal of Virology (01.04.1998)
Get full text
Journal Article
A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced by That of Bovine PIV3 Is Attenuated in Primates
Bailly, J E, McAuliffe, J M, Durbin, A P, Elkins, W R, Collins, P L, Murphy, B R
Published in Journal of Virology (01.04.2000)
Published in Journal of Virology (01.04.2000)
Get full text
Journal Article
Comparison of the Immunogenicity and Efficacy of a Replication-Defective Vaccinia Virus Expressing Antigens of Human Parainfluenza Virus Type 3 (HPIV3) with Those of a Live Attenuated HPIV3 Vaccine Candidate in Rhesus Monkeys Passively Immunized with PIV3 Antibodies
Durbin, Anna P., Cho, Chris J., Elkins, William R., Wyatt, Linda S., Moss, Bernard, Murphy, Brian R.
Published in The Journal of infectious diseases (01.06.1999)
Published in The Journal of infectious diseases (01.06.1999)
Get full text
Journal Article
The live attenuated chimeric vaccine rWN/DEN4 Delta 30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Durbin, Anna, Wright, Peter, Cox, Amber, Kagucia, Wangeci, Elwood, Daniel, Henderson, Susan, Wanionek, Kimberli, Speicher, Jim, Whitehead, Stephen, Pletnev, Alexander
Published in Vaccine (19.11.2013)
Published in Vaccine (19.11.2013)
Get full text
Journal Article
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers
Levine, Myron M, Abdullah, Salim, Arabi, Yaseen M, Darko, Delese Mimi, Durbin, Anna P, Estrada, Vicente, Jamrozik, Euzebiusz, Kremsner, Peter G, Lagos, Rosanna, Pitisuttithum, Punnee, Plotkin, Stanley A, Sauerwein, Robert, Shi, Sheng-Li, Sommerfelt, Halvor, Subbarao, Kanta, Treanor, John J, Vrati, Sudhanshu, King, Deborah, Balasingam, Shobana, Weller, Charlie, Aguilar, Anastazia Older, Cassetti, M Cristina, Krause, Philip R, Restrepo, Ana Maria Henao
Published in Clinical infectious diseases (28.08.2020)
Published in Clinical infectious diseases (28.08.2020)
Get full text
Journal Article
TV005 dengue vaccine protects against dengue serotype 2 and 3 controlled human infection
Pierce, Kristen K., Durbin, Anna P., Walsh, Mary-Claire, Carmolli, Marya, Sabundayo, Beulah P., Dickson, Dorothy M., Diehl, Sean A., Whitehead, Stephen S., Kirkpatrick, Beth D.
Published in The Journal of clinical investigation (16.11.2023)
Published in The Journal of clinical investigation (16.11.2023)
Get full text
Journal Article
Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2 Delta 30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain
Grifoni, Alba, Angelo, Michael, Sidney, John, Paul, Sinu, Peters, Bjoern, de Silva, Aruna D, Phillips, Elizabeth, Mallal, Simon, Diehl, Sean A, Botten, Jason
Published in Journal of virology (01.04.2017)
Published in Journal of virology (01.04.2017)
Get full text
Journal Article
The Type-Specific Neutralizing Antibody Response Elicited by a Dengue Vaccine Candidate Is Focused on Two Amino Acids of the Envelope Protein: e1003761
VanBlargan, Laura A, Mukherjee, Swati, Dowd, Kimberly A, Durbin, Anna P, Whitehead, Stephen S, Pierson, Theodore C
Published in PLoS pathogens (01.12.2013)
Published in PLoS pathogens (01.12.2013)
Get full text
Journal Article
Corrigendum to ''Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model'' EBioMedicine 41 (2019) 465-478
Nivarthi, Usha K, Tu, Huy A, Delacruz, Matthew J, Swanstrom, Jesica, Patel, Bhumi, Durbin, Anna P, Whitehead, Stephen S, Pierce, Kristen K, Kirkpatrick, Beth D, Baric, Ralph S, Nguyen, Ngan, Emerling, Daniel E, de Silva, Aravinda M, Diehl, Sean A
Published in EBioMedicine (01.04.2020)
Published in EBioMedicine (01.04.2020)
Get full text
Journal Article
Joint statement in support of hepatitis C human challenge studies
Alter, Harvey J, Barnes, Eleanor, Biondi, Mia J, Cox, Andrea L, Eberts, Jake D, Feld, Jordan J, Liang, T Jake, Morrison, Josh, Rice, Charles M, Shoukry, Naglaa H, Thomas, David L, Van Gennip, Jennifer, Weijer, Charles
Published in The lancet. Gastroenterology & hepatology (01.11.2023)
Published in The lancet. Gastroenterology & hepatology (01.11.2023)
Get more information
Journal Article
The live attenuated chimeric vaccine rWN/DEN4[delta]30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Durbin, Anna P, Wright, Peter F, Cox, Amber, Kagucia, Wangeci, Elwood, Daniel, Henderson, Susan, Wanionek, Kimberli, Speicher, Jim, Whitehead, Stephen S, Pletnev, Alexander G
Published in Vaccine (19.11.2013)
Published in Vaccine (19.11.2013)
Get full text
Journal Article
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection modelResearch in context
Usha K. Nivarthi, Huy A. Tu, Matthew J. Delacruz, Jesica Swanstrom, Bhumi Patel, Anna P. Durbin, Stephen S. Whitehead, Kristen K. Pierce, Beth D. Kirkpatrick, Ralph S. Baric, Ngan Nguyen, Daniel E. Emerling, Aravinda M. de Silva, Sean A. Diehl
Published in EBioMedicine (01.03.2019)
Get full text
Published in EBioMedicine (01.03.2019)
Journal Article
Phase I Clinical Evaluation of rDEN4 Delta 30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity
McArthur, J H, Durbin, A P, Marron, JA, Wanionek, KA, Thumar, B, Pierro, D J, Schmidt, A C, Blaney, JE Jr, Murphy, B R, Whitehead, S S
Published in The American journal of tropical medicine and hygiene (01.11.2008)
Published in The American journal of tropical medicine and hygiene (01.11.2008)
Get full text
Journal Article
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine: The Development of Dengue Vaccines
DURBIN, Anna P, KIRKPATRICK, Beth D, PIERCE, Kristen K, SCHMIDT, Alexander C, WHITEHEAD, Stephen S
Published in Vaccine (2011)
Get full text
Published in Vaccine (2011)
Journal Article
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region
Durbin, AP, Karron, RA, Sun, W, Vaughn, DW, Reynolds, MJ, Perreault, , JR, Thumar, B, Men, R, Lai, CJ, Elkins, WR, Chanock, RM, Murphy, BR, Whitehead, SS
Published in The American journal of tropical medicine and hygiene (01.11.2001)
Published in The American journal of tropical medicine and hygiene (01.11.2001)
Get full text
Journal Article
HIV-1 Evolution Following Transmission to an HLA-B 5801-Positive Patient
O'Connell, Karen A., Xu, Jie, Durbin, Anna P., Apuzzo, Linda G., Imteyaz, Hejab, Williams, Thomas M., Ray, Stuart C., Margolick, Joseph B., Siliciano, Robert F., Blankson, Joel N.
Published in The Journal of infectious diseases (15.12.2009)
Published in The Journal of infectious diseases (15.12.2009)
Get full text
Journal Article
HIV-1 Evolution Following Transmission to an HLA-B5801 Positive Subject
O’Connell, Karen A., Xu, Jie, Durbin, Anna P., Apuzzo, Linda G., Imteyaz, Hejab, Williams, Thomas M., Ray, Stuart C., Margolick, Joseph B., Siliciano, Robert F., Blankson, Joel N.
Published in The Journal of infectious diseases (15.12.2009)
Published in The Journal of infectious diseases (15.12.2009)
Get full text
Journal Article
A single dose of the DENV-1 candidate vaccine rDEN1[DELTA]30 is strongly immunogenic and induces resistance to a second dose in a randomized trial
Durbin, Anna P, Whitehead, Stephen S, Shaffer, Donna, Elwood, Dan, Wanionek, Kimberli, Thumar, Bhavin, Blaney, Joseph E, Murphy, Brian R, Schmidt, Alexander C
Published in PLoS neglected tropical diseases (01.08.2011)
Published in PLoS neglected tropical diseases (01.08.2011)
Get full text
Journal Article